TScan Therapeutics, Inc. (TCRX) Form 10-K Annual Reports
TScan Therapeutics, Inc. (TCRX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TCRX
CIK: 1783328
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJames Holmes
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-16 | 2026-11-20 | PRE 14A | 0001193125-26-424240 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-13 | 8-K | 0001193125-26-424198 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412521 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412518 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-24 | 8-K | 0001193125-26-409199 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-25 | — | SCHEDULE 13G Filing | 0002063423-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-08 | 8-K | 0001193125-26-388631 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-27 | 8-K | 0001193125-26-379343 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-12 | 8-K | 0001193125-26-355664 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003526 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002183 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345749 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345732 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-22 | 8-K | 0001193125-26-276693 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236870 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-20 | 8-K | 0001193125-26-236862 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236855 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236854 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236848 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236844 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | 4 | 0001193125-26-236841 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000921895-26-001399 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001193125-26-207572 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001193125-26-207549 | View SEC Doc Filr Page |
| ARS | 2026-04-17 | 2025-12-31 | ARS | 0001193125-26-160310 | View SEC Doc Filr Page |